Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa2g04869 | ATGGCCAAAACTTCCAATTTCTCCCATCTTTTCAACTTCATGTCAATTTTGTTACTCATTTTCCCTCCATGTGAATCTCAAACAACCGAAACACAAGCACTTCTTCAATTCAAAGATCATTTAACCGATTCATTGAACACATTAGCTTCATGGAATAATTCAAACACTCCATGCAACTTTCATGGAATCACATGTGATCCATCATCCTTCAAAGTCATAGAAATCTCCTTAGATGATAACTCCCTCTCGGGCGAAATTTTTCAATCAATATCAATTCTTCACAGCCTGCAAGTCCTTTCACTTCCATCCAACTCCATTTCCGGAAAACTTCCACTAGAAGTAACCGAATTCACACACCTAAGAGTCTTGAATTTATCCGGAAACGAACTGGTTGGTTCGATTCCAGATTTTTCTGGACTAAGAAACCTTCGTGTGCTTGATCTTTCTGCGAACTTTTTCACCGGTCGAATCCCTGGCTGGATAGGGAATCTAACCGGACTAGTTTCGCTCGGCCTCGGAGAAAATCTTTACACGGGAAGTGTGATTCCCAAGAGTCTTGGAAACTTGAAGAACTTGACATGGCTTTACCTTGGTGGTGCACATTTGGTTGGAGAGATTCCAGAATCATTGTATGAACTGGAAGCATTAGAGACTTTGGATTTGTCAAGAAACAAGCTATCTGGCGAAATCTCTAGATCGATTTCGAAGCTGAAGAATGTTTACAAAATCGAGTTGTTTTCGAACAATTTGACCGGAGGAATACCGGAAGAAGTTGCGAATTTAACCAATTTGCAAGAGATTGATATTTCTGCAAACAACCTGTTTGGTGAATTGCCTAAGAGAATAGGTGATATGGTGAATTTGGCTGTTTTTCAGCTCTATGATAACAATTTCTCTGGTGAGATTCCTGTTGGATTTGGTGATATGGAAAATCTCAGAGGCTTTTCGGTTTACAGAAACAGTTTCACCGGTTCGATTCCGGAGAATTTCGGCCGATTTTCTCCGCTCGAAAGCATCGATGTGTCTGAGAATCAGTTTTCAGGTTTTTTCCCAAAGTACTTGTGTGAGAAGCAAAAGTTGACAATTCTGCTAGCATTGCAAAACAATTTCTCTGGTAATATTTCAGATTCTTATGCTTCATGCAAATCATTAGAGAGATTGAGGGTCAGTAGGAATTTTTTGTCTGGAAACATTCCGAATGGTGTTTGGTCGCTTCCGAATGCGAAGATAATTGATCTCGGGTTTAACAATTTCAGTGGTAAAGTTTCTTCTCAGATTGGTAACTCAACAAATTTAACTGAGGTTGTTTTGATGAACAACAAGTTTTCTGGTAAGGTTCCCTCGGAAATCGGAAAATTGGTGAATTTGGAGAAACTTTACTTGAGTAACAACAATTTCTCTGGTGAAATTCCTCATGAAATTGGATTTTTGAAACAGTTATCCACTTTGCATTTGGAGGAAAATTCCTTAACTGGTTTGATACCTAAAGAGTTAGGCCATTGCTCAAGGCTTGTGGACTTGAATTTTGCATTGAATTCTCTATCAGGTAATATTCCGAGCTCGGTTTCGCTTATGAGTTCGTTGAATTCGTTGAATTTGTCTCGAAACAAGTTGACAGGTTCGATTCCTGATAATTTGGACAAAATGAAACTAAGTTCAGTTGATTTTTCTTATAATCTGCTTACTGGCGGAATTCCGTTTGGGATACTTGTCATCGGCGGAGAGAAAGCTTTTGCTGGAAACAAAGGTTTATGTGTTGAGAAAATTCCGAGCAGTAAGATAAATTCGGCTTTGAAGATTTGTGGTAATGATCGTGGTCGTAGAAGAGCTTTCTTTGGTTATAAATATATATTGCTCTTGGTCATTGCTGTCATCTTCGTCGCTGCGGTTTTGATATGTAGAAGCGTGAGGATTCGAAGAGCGAAAAAGATACTAAAATGTCAGAAGGAAGCGAGTCAGAGAAAATGGAAACAAGCATCTTTTCACAAAGTGGATATTGATGCTGATGAAATATGTAATTTGAATGAAGATAATTTGATCGGCCACGGTGGTACGGGAAAGGTTTATCGAGTCGCGTTGAAGAAAAACGGAATGGTAGTGGCCGTGAAGCAGCTAGAGAAAAGCGACGGTATGAGGATTTTAGTTGCGGAAATGGAGATTTTAGGGAAGATTAGGCATAGAAATATACTTAAATTGTATGCTTGTTTTCTCAAAGGAGGAACCAATCTTTTGGTTTTTGAGTATATGCCAAATGGTAATCTTTTTGAAGCTCTTCATAGAAATGTAAAAGATGAGAAGGTTGCATGGGATTGGAATCAGAGGTATAAAATCGCGTTGGGAGGTGCAAAAGGGATTTGCTATTTGCACCATGATTGTTGTCCATCGGTTATTCATAGGGATATAAAATCGAGCAACATCTTGCTTGATCAAGAATATGAGGCGAAAATTGCTGATTTTGGTGTTGCAAGGTTTGCTGAACAAACTCAGACGGGTCTTAGCTATTTTGCTGGTACACATGGTTATATTGCTCCAGAACTTGCGTATTCAACTGAAGTAACTGAAAAAAGCGATGTGTACAGCTTCGGAGTAGTACTGTTAGAGTTAGTATCGGGAAGAAAAGCTGTTGAAGAAGAATACGGAGACGCAAAAGACATTGTTTATTGGGTTCTGAGTAATCTGAATGAGCGCGAAAGTGTAATCAACATTCTTGATGCGAGGGTTGCATCAGCACATTGTGTTGACGATATGATAAAAGTGTTGAAAATTGCTATTAAGTGCACTAATAAACTTCCGACATTGCGTCCTACAATGAGAGATGTTGTTAAGATGCTTATTGCTTCTGAACCTTGCAAGAAGAAATCTAAAAGGCACGGTTTTGAGAAAGATTTAATGTCTAAAGCTACAATTTGA | 2910 | 0.3876 | MAKTSNFSHLFNFMSILLLIFPPCESQTTETQALLQFKDHLTDSLNTLASWNNSNTPCNFHGITCDPSSFKVIEISLDDNSLSGEIFQSISILHSLQVLSLPSNSISGKLPLEVTEFTHLRVLNLSGNELVGSIPDFSGLRNLRVLDLSANFFTGRIPGWIGNLTGLVSLGLGENLYTGSVIPKSLGNLKNLTWLYLGGAHLVGEIPESLYELEALETLDLSRNKLSGEISRSISKLKNVYKIELFSNNLTGGIPEEVANLTNLQEIDISANNLFGELPKRIGDMVNLAVFQLYDNNFSGEIPVGFGDMENLRGFSVYRNSFTGSIPENFGRFSPLESIDVSENQFSGFFPKYLCEKQKLTILLALQNNFSGNISDSYASCKSLERLRVSRNFLSGNIPNGVWSLPNAKIIDLGFNNFSGKVSSQIGNSTNLTEVVLMNNKFSGKVPSEIGKLVNLEKLYLSNNNFSGEIPHEIGFLKQLSTLHLEENSLTGLIPKELGHCSRLVDLNFALNSLSGNIPSSVSLMSSLNSLNLSRNKLTGSIPDNLDKMKLSSVDFSYNLLTGGIPFGILVIGGEKAFAGNKGLCVEKIPSSKINSALKICGNDRGRRRAFFGYKYILLLVIAVIFVAAVLICRSVRIRRAKKILKCQKEASQRKWKQASFHKVDIDADEICNLNEDNLIGHGGTGKVYRVALKKNGMVVAVKQLEKSDGMRILVAEMEILGKIRHRNILKLYACFLKGGTNLLVFEYMPNGNLFEALHRNVKDEKVAWDWNQRYKIALGGAKGICYLHHDCCPSVIHRDIKSSNILLDQEYEAKIADFGVARFAEQTQTGLSYFAGTHGYIAPELAYSTEVTEKSDVYSFGVVLLELVSGRKAVEEEYGDAKDIVYWVLSNLNERESVINILDARVASAHCVDDMIKVLKIAIKCTNKLPTLRPTMRDVVKMLIASEPCKKKSKRHGFEKDLMSKATI | 969 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa2g04869 | 969 | ProSitePatterns | Protein kinases ATP-binding region signature. | 680 | 703 | IPR017441 | GO:0005524 | |
Vifa2g04869 | 969 | FunFam | Receptor-like protein kinase HSL1 | 287 | 593 | - | - | |
Vifa2g04869 | 969 | SMART | LRR_typ_2 | 525 | 549 | IPR003591 | - | |
Vifa2g04869 | 969 | SMART | LRR_typ_2 | 117 | 139 | IPR003591 | - | |
Vifa2g04869 | 969 | SMART | LRR_typ_2 | 477 | 500 | IPR003591 | - | |
Vifa2g04869 | 969 | SMART | LRR_typ_2 | 261 | 285 | IPR003591 | - | |
Vifa2g04869 | 969 | SMART | LRR_typ_2 | 213 | 237 | IPR003591 | - | |
Vifa2g04869 | 969 | SMART | LRR_typ_2 | 140 | 164 | IPR003591 | - | |
Vifa2g04869 | 969 | SMART | LRR_typ_2 | 453 | 475 | IPR003591 | - | |
Vifa2g04869 | 969 | SMART | serkin_6 | 674 | 951 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g04869 | 969 | Pfam | Leucine Rich Repeat | 216 | 237 | IPR001611 | GO:0005515 | |
Vifa2g04869 | 969 | Pfam | Leucine Rich Repeat | 455 | 477 | IPR001611 | GO:0005515 | |
Vifa2g04869 | 969 | SUPERFAMILY | RNI-like | 243 | 563 | - | - | |
Vifa2g04869 | 969 | ProSiteProfiles | Protein kinase domain profile. | 674 | 960 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g04869 | 969 | ProSiteProfiles | Leucine-rich repeat profile. | 119 | 141 | IPR001611 | GO:0005515 | |
Vifa2g04869 | 969 | Gene3D | Ribonuclease Inhibitor | 237 | 308 | IPR032675 | - | |
Vifa2g04869 | 969 | Gene3D | Ribonuclease Inhibitor | 181 | 236 | IPR032675 | - | |
Vifa2g04869 | 969 | FunFam | Leucine-rich receptor-like protein kinase family protein | 183 | 280 | - | - | |
Vifa2g04869 | 969 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 | 749 | 961 | - | - | |
Vifa2g04869 | 969 | Pfam | Protein kinase domain | 676 | 942 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g04869 | 969 | Pfam | Leucine rich repeat N-terminal domain | 29 | 66 | IPR013210 | - | |
Vifa2g04869 | 969 | Gene3D | Transferase(Phosphotransferase) domain 1 | 749 | 966 | - | - | |
Vifa2g04869 | 969 | FunFam | Probable inactive receptor kinase RLK902 | 27 | 182 | - | - | |
Vifa2g04869 | 969 | Gene3D | Ribonuclease Inhibitor | 26 | 180 | IPR032675 | - | |
Vifa2g04869 | 969 | Gene3D | Ribonuclease Inhibitor | 309 | 596 | IPR032675 | - | |
Vifa2g04869 | 969 | PRINTS | Leucine-rich repeat signature | 216 | 229 | - | - | |
Vifa2g04869 | 969 | PRINTS | Leucine-rich repeat signature | 525 | 538 | - | - | |
Vifa2g04869 | 969 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 213 | 945 | - | - | |
Vifa2g04869 | 969 | FunFam | Leucine-rich receptor-like protein kinase family protein | 664 | 748 | - | - | |
Vifa2g04869 | 969 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 796 | 808 | IPR008271 | GO:0004672|GO:0006468 | |
Vifa2g04869 | 969 | Gene3D | Phosphorylase Kinase; domain 1 | 635 | 748 | - | - | |
Vifa2g04869 | 969 | SUPERFAMILY | L domain-like | 26 | 288 | - | - | |
Vifa2g04869 | 969 | Pfam | Leucine rich repeat | 141 | 201 | IPR001611 | GO:0005515 | |
Vifa2g04869 | 969 | SUPERFAMILY | Protein kinase-like (PK-like) | 672 | 944 | IPR011009 | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa2g04869 | Vifa-Chr2 | 1451294933 | 1451298105 | Dispersed/Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa2g04869 | 15 | 955 | Receptor kinase-like Gene Family | AT1G72180 | 53.410 | 0.0 | 979 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Vifa2g04869 | Pkinase | 3.5e-49 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa2g04869 | - | - | gmx:100789704 | 1315.44 |